Cargando…
Inhibition of Tumor Microenvironment Cytokine Signaling Sensitizes Ovarian Cancer Cells to Antiestrogen Therapy
SIMPLE SUMMARY: Antiestrogen hormonal therapy is a relatively low side effect, orally administered cancer treatment option, yet response rates have been limited in epithelial ovarian cancer despite estrogen receptor expression in many tumors. This suggests that other pathways impact estrogen respons...
Autores principales: | Tan, Lijun, Tondo-Steele, Katelyn, Foster, Caroline, McIlwain, Carrie, Bolland, Danielle E., Crawford, Howard C., Sciallis, Andrew, McLean, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564160/ https://www.ncbi.nlm.nih.gov/pubmed/36230597 http://dx.doi.org/10.3390/cancers14194675 |
Ejemplares similares
-
The “Sweet Spot” of Targeting Tumor Metabolism in Ovarian Cancers
por: Tondo-Steele, Katelyn, et al.
Publicado: (2022) -
The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018) -
The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
por: Suba, Zsuzsanna
Publicado: (2015) -
Leukemia Inhibitory Factor Functions in Parallel with Interleukin-6 to Promote Ovarian Cancer Growth
por: McLean, Karen, et al.
Publicado: (2018) -
An introduction to the biology of vision /
por: McIlwain, James T.
Publicado: (1996)